These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A role for voltage gated T-type calcium channels in mediating "capacitative" calcium entry? Gackière F; Bidaux G; Lory P; Prevarskaya N; Mariot P Cell Calcium; 2006 Apr; 39(4):357-66. PubMed ID: 16442617 [TBL] [Abstract][Full Text] [Related]
3. A selective T-type Ca2+ channel blocker R(-) efonidipine. Shin MC; Kim CJ; Min BI; Ogawa S; Tanaka E; Akaike N Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun; 377(4-6):411-21. PubMed ID: 18278483 [TBL] [Abstract][Full Text] [Related]
4. Role of membrane depolarization and T-type Ca2+ channels in angiotensin II and K+ stimulated aldosterone secretion. Lotshaw DP Mol Cell Endocrinol; 2001 Apr; 175(1-2):157-71. PubMed ID: 11325526 [TBL] [Abstract][Full Text] [Related]
5. T-Type Calcium Channel Inhibitors Induce Apoptosis in Medulloblastoma Cells Associated with Altered Metabolic Activity. Sedeeq M; Maklad A; Dutta T; Feng Z; Wilson R; Gueven N; Azimi I Mol Neurobiol; 2022 May; 59(5):2932-2945. PubMed ID: 35243582 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of effects of T and N type calcium channel blockers on the electroencephalogram recordings in Wistar Albino Glaxo/Rij rats, an absence epilepsy model. Durmus N; Gültürk S; Kaya T; Demir T; Parlak M; Altun A Indian J Pharmacol; 2015; 47(1):34-8. PubMed ID: 25821308 [TBL] [Abstract][Full Text] [Related]
7. Antihypertensive effects of the putative T-type calcium channel antagonist mibefradil are mediated by the L-type calcium channel Cav1.2. Moosmang S; Haider N; Brüderl B; Welling A; Hofmann F Circ Res; 2006 Jan; 98(1):105-10. PubMed ID: 16306443 [TBL] [Abstract][Full Text] [Related]
8. CaV3.2 T-type calcium channels in peripheral sensory neurons are important for mibefradil-induced reversal of hyperalgesia and allodynia in rats with painful diabetic neuropathy. Obradovic ALj; Hwang SM; Scarpa J; Hong SJ; Todorovic SM; Jevtovic-Todorovic V PLoS One; 2014; 9(4):e91467. PubMed ID: 24705276 [TBL] [Abstract][Full Text] [Related]
9. Effect of mibefradil on sodium and calcium currents. Strege PR; Bernard CE; Ou Y; Gibbons SJ; Farrugia G Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G249-53. PubMed ID: 15790762 [TBL] [Abstract][Full Text] [Related]
10. Single-channel pharmacology of mibefradil in human native T-type and recombinant Ca(v)3.2 calcium channels. Michels G; Matthes J; Handrock R; Kuchinke U; Groner F; Cribbs LL; Pereverzev A; Schneider T; Perez-Reyes E; Herzig S Mol Pharmacol; 2002 Mar; 61(3):682-94. PubMed ID: 11854450 [TBL] [Abstract][Full Text] [Related]
11. Towards selective antagonists of T-type calcium channels: design, characterization and potential applications of NNC 55-0396. Li M; Hansen JB; Huang L; Keyser BM; Taylor JT Cardiovasc Drug Rev; 2005; 23(2):173-96. PubMed ID: 16007233 [TBL] [Abstract][Full Text] [Related]
12. NNC 55-0396 [(1S,2S)-2-(2-(N-[(3-benzimidazol-2-yl)propyl]-N-methylamino)ethyl)-6-fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphtyl cyclopropanecarboxylate dihydrochloride]: a new selective inhibitor of T-type calcium channels. Huang L; Keyser BM; Tagmose TM; Hansen JB; Taylor JT; Zhuang H; Zhang M; Ragsdale DS; Li M J Pharmacol Exp Ther; 2004 Apr; 309(1):193-9. PubMed ID: 14718587 [TBL] [Abstract][Full Text] [Related]